The rampant spread of coronavirus in Iran was a problem largely the result of the Islamic Republic’s own making. In early February, Iranian officials were aware of a potential problem in the city of Qom, where a shrine holy to Shia Muslims served as a breeding ground for the transmission of the virus. Yet authorities took no action to quarantine the city or even warn residents to take safety precautions. The shrine still remains open to visitors and video has recently emerged showing people licking the shrine. …
Iran’s bumbling and incompetence in dealing with the health crisis can be attributed to the Islamic Republic’s unwillingness to acknowledge weakness and vulnerability. Its healthcare system is woefully inadequate. There are dire shortages of masks, medicines and testing kits. In the final analysis, the regime’s deceit, incompetence and corruption has spread fear and cost lives.
Contrast that with Israel:
The Migal Research Institute, an Israeli company based in Galilee has announced that they are on the cusp of developing a coronavirus vaccine. The company had been developing a vaccine for coronavirus in chickens and recognized that they could tweak their vaccine to combat coronavirus in humans. According to Migal’s CEO, David Zigdon, a vaccine for humans could be ready in a few months. …
Researchers at Israel’s Bar-Ilan University have developed technologies that drastically reduce the time needed to analyze saliva samples for the presence of COVID-19. This technology reduces the time to analyze a sample from an hour to approximately 15 minutes.
Ordinary disposable facemasks cannot block all pathogens because there are openings in the mask. Moreover, they do not kill the pathogens. Two Israeli companies have developed facemasks that can kill the coronavirus. Sonovia, an Israeli startup with labs in Ramat Gan, says it is developing virus resistant masks and textiles by using a nanotechnology process to infuse textiles with antibacterial chemicals.
A second Israeli company, Jerusalem-based Argaman, has developed a reusable, washable, breathable antiviral facemask called Bio-Block. Bio-Block masks kill pathogens going both to the wearer and away from the wearer. Argaman founder and CEO, Jeff Gabbay, says that the product is nearing commercialization. Moreover, Gabbay states that the anti-viral properties incorporated in the masks can also be incorporated in textiles, like hospital towels and gowns.
Finally, the Israelis have developed treatments for those already infected with COVID-19, who often present with respiratory ailments such as pneumonia. CoughSync, which was developed at Alyn Hospital, a Jerusalem pediatric and adolescent rehabilitation facility, is a device that helps pneumonia victims get rid of phlegm. Current methods involve disconnecting the patient from a ventilator and then using a catheter to suction up secretions. This method is not only invasive, it needlessly exposes the healthcare worker to infection. By contrast, the CoughSync device replicates what a cough would do, and this artificial cough removes the secretions effectively in a noninvasive manner.
The left wants to boycott Israel and buddy up to Iran. It will be interesting to see who buys the Israeli breakthroughs.
hat-tip Stephen Neil